ENSYSCE BIOSCIENCES, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Sep 2017 | — | $20.0K | — |
| Dec 2017 | — | $5.0M | — |
| Dec 2017 | — | $5.0M | — |
| Mar 2018 | — | $5.0M | — |
| Jun 2018 | — | $5.0M | — |
| Sep 2018 | — | $5.0M | — |
| Dec 2018 | — | $5.0M | — |
| Mar 2019 | — | $5.0M | — |
| Jun 2019 | — | $5.0M | — |
| Sep 2019 | — | $5.0M | — |
| Dec 2019 | — | $5.0M | — |
| Mar 2020 | — | $4.5M | — |
| Jun 2020 | — | $-2.7M | — |
| Sep 2020 | — | $1.5M | — |
| Dec 2020 | — | $-6.4M | $194.2K |
| Mar 2021 | — | $1.9M | — |
| Jun 2021 | — | $5.4M | $8.0M |
| Sep 2021 | — | $-105.7K | $6.8M |
| Dec 2021 | — | $-7.9M | $12.3M |
| Mar 2022 | — | $1.4M | $8.4M |
| Jun 2022 | — | $-491.6K | $3.7M |
| Sep 2022 | — | $-6.1M | $4.5M |
| Dec 2022 | — | $-3.7M | $3.1M |
| Mar 2023 | — | $166.7K | $1.4M |
| Jun 2023 | — | $4.1M | $3.8M |
| Sep 2023 | — | $1.5M | $1.5M |
| Dec 2023 | — | $-322.9K | $1.1M |
| Mar 2024 | — | $3.7M | $3.4M |
| Jun 2024 | — | $1.8M | $1.0M |
| Sep 2024 | — | $6.9M | $4.2M |
| Dec 2024 | — | $3.7M | $3.5M |
| Mar 2025 | — | $3.0M | $3.1M |
| Jun 2025 | — | $3.4M | $2.2M |
| Sep 2025 | — | $1.2M | $1.7M |
| Dec 2025 | — | $3.2M | $4.3M |
| Mar 2026 | — | $-340.0K | $745.5K |
| Jun 2026 | — | $-781.7K | $676.7K |